» Articles » PMID: 21188479

Risk Factors for Type 2 Diabetes in Groups Stratified According to Metabolic Syndrome: a 10-year Follow-up of the Tromsø Study

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 2010 Dec 29
PMID 21188479
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Many incident cases of type 2 diabetes do not fulfil the metabolic syndrome, which accordingly has been questioned both as a research and clinical tool. The aim of this study was to determine differences in risk factors for type 2 diabetes between groups with high or low metabolic score. The study population were 26,093 men and women attending the Tromsø Study in 1994, followed through 2005, and who did not have diabetes when entering the study. A total of 492 incident cases of type 2 diabetes were registered. A metabolic score was defined according to a modified version of the National Cholesterol Education Program Adult Treatment Panel III. For those fulfilling ≥ 3 metabolic score criteria, increasing age, body mass index (BMI), triglycerides and a family history of diabetes were independent predictors. Age, BMI, and triglycerides predicted type 2 diabetes more strongly in subjects with low metabolic score, whereas high HDL cholesterol was not protective in this low risk group. The risk associated with a positive family history was unaffected by level of metabolic score. In addition smoking, low education and in men also physical inactivity were independent risk factors only in those with low metabolic score. Adding these non-metabolic risk factors increased correct classification from an ROC area of 77.2 to 87.1% (P value < 0.0001). One half of the incident cases of type 2 diabetes were missed by using high metabolic score for risk prediction.

Citing Articles

Longitudinal assessment of classic and 11-oxygenated androgen concentrations and their association with type 2 diabetes mellitus development: the Tromsø study.

Allaoui G, Rylander C, Fuskevag O, Grimnes G, Averina M, Wilsgaard T Acta Diabetol. 2024; 61(7):847-857.

PMID: 38498076 PMC: 11182793. DOI: 10.1007/s00592-024-02266-5.


Personal continuity of GP care and outpatient specialist visits in people with type 2 diabetes: A cross-sectional survey.

Hansen A, Johansen M PLoS One. 2022; 17(10):e0276054.

PMID: 36282805 PMC: 9595526. DOI: 10.1371/journal.pone.0276054.


Pancreas-Its Functions, Disorders, and Physiological Impact on the Mammals' Organism.

Karpinska M, Czauderna M Front Physiol. 2022; 13:807632.

PMID: 35431983 PMC: 9005876. DOI: 10.3389/fphys.2022.807632.


An Innovative Approach for Decision-Making on Designing Lifestyle Programs to Reduce Type 2 Diabetes on Dutch Population Level Using Dynamic Simulations.

Sluijs T, Lokkers L, Ozsezen S, Veldhuis G, Wortelboer H Front Public Health. 2021; 9:652694.

PMID: 33996729 PMC: 8116515. DOI: 10.3389/fpubh.2021.652694.


Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994-2016.

Langholz P, Wilsgaard T, Njolstad I, Jorde R, Hopstock L BMJ Open. 2021; 11(3):e041846.

PMID: 33757943 PMC: 7993331. DOI: 10.1136/bmjopen-2020-041846.


References
1.
Sattar N, McConnachie A, Shaper A, Blauw G, Buckley B, de Craen A . Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008; 371(9628):1927-35. DOI: 10.1016/S0140-6736(08)60602-9. View

2.
Sattar N . Why metabolic syndrome criteria have not made prime time: a view from the clinic. Int J Obes (Lond). 2008; 32 Suppl 2:S30-4. DOI: 10.1038/ijo.2008.33. View

3.
Ford E, Giles W, Dietz W . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287(3):356-9. DOI: 10.1001/jama.287.3.356. View

4.
Jacobsen B, Bonaa K, Njolstad I . Cardiovascular risk factors, change in risk factors over 7 years, and the risk of clinical diabetes mellitus type 2. The Tromsø study. J Clin Epidemiol. 2002; 55(7):647-53. DOI: 10.1016/s0895-4356(02)00404-3. View

5.
Ridker P, Buring J, Cook N, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107(3):391-7. DOI: 10.1161/01.cir.0000055014.62083.05. View